Year archive

SYNLAB AG — 2023 filings

All 40 regulatory filings released by SYNLAB AG (SYAB) in 2023, sourced directly from the official regulator.

40 Filings

2023 Period

2023 filings (40)

Filing	Released	Lang
Q3 statement / Q3 financial report 2023 Interim / Quarterly Report 9M 2023	2023-11-28	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-11-27	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-11-24	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-11-23	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-11-23	English
Continued strong performance in the third quarter of 2023 Earnings Release 9M 2023	2023-11-08	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-11-07	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-11-07	English
SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven M&A Activity	2023-11-02	English
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B Regulatory Filings	2023-10-10	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-10-05	English
Report Publication Announcement 2023 Report Publication Announcement	2023-10-05	English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis zum 30.06.2024 Report Publication Announcement	2023-10-05	German
Hinweis auf Konzernabschluss vom 01.01.2023 bis zum 31.12.2023 Report Publication Announcement	2023-10-05	German
SYNLAB AG: Ebsworth GmbH, sell Director's Dealing	2023-10-02	English
SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven M&A Activity	2023-09-29	English
SYNLAB AG: Cinven announces public acquisition offer \| Conclusion of Investment Agreement M&A Activity	2023-09-29	English
Half-yearly financial report 2023 Interim / Quarterly Report H2 2023	2023-08-17	English
SYNLAB AG: SYNLAB agrees to sell its veterinary diagnostics business to Mars M&A Activity	2023-08-14	English
SYNLAB AG: Continued strong performance in the second quarter of 2023 Earnings Release H1 2023	2023-08-09	English
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2023 bis zum 30.06.2023 Interim / Quarterly Report H1 2023	2023-08-09	German
SYNLAB AG: SYNLAB plays key role in the largest ever multinational study on cholesterol Regulatory Filings	2023-07-17	English
SYNLAB AG: SYNLAB invests in innovative Healthcare Centre in Florence Regulatory Filings	2023-06-28	English
SYNLAB AG: SYNLAB agrees to sell Swiss business to Sonic Healthcare M&A Activity	2023-06-27	English
Q1 statement / Q1 financial report 2023 Interim / Quarterly Report Q1 2023	2023-05-12	German
SYNLAB AG: SYNLAB reports strong start to fiscal year 2023 Earnings Release Q1 2023	2023-05-10	English
SYNLAB AG: SYNLAB invests in new, cutting-edge laboratory in Munich and further expands its leading position in the region (news with additional features) Regulatory Filings	2023-05-09	English
SYNLAB AG: Bekanntmachung der Einberufung zur Hauptversammlung am 17.05.2023 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2023-04-05	German
Annual financial report 2022 Annual Report FY 2022	2023-03-31	English
SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022 Earnings Release FY 2022	2023-03-16	English
SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO Board/Management Information	2023-03-15	English
SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share M&A Activity	2023-03-13	English
SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing Earnings Release FY 2022	2023-02-06	English
SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes Earnings Release FY 2023	2023-02-06	English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021 Audit Report / Information FY 2021	2023-02-01	German
Report Publication Announcement 2023 Report Publication Announcement	2023-01-23	English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023 Report Publication Announcement	2023-01-23	German
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022 Report Publication Announcement	2023-01-23	German
SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market SYNLABs operations in Portugal included in such investigation Legal Proceedings Report	2023-01-04	English
SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB Legal Proceedings Report	2023-01-04	English